Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 261

1.

Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFNα-driven lupus nephritis.

Katewa A, Wang Y, Hackney JA, Huang T, Suto E, Ramamoorthi N, Austin CD, Bremer M, Chen JZ, Crawford JJ, Currie KS, Blomgren P, DeVoss J, DiPaolo JA, Hau J, Johnson A, Lesch J, DeForge LE, Lin Z, Liimatta M, Lubach JW, McVay S, Modrusan Z, Nguyen A, Poon C, Wang J, Liu L, Lee WP, Wong H, Young WB, Townsend MJ, Reif K.

JCI Insight. 2017 Apr 6;2(7):e90111. doi: 10.1172/jci.insight.90111.

2.

A potential therapeutic strategy for chronic lymphocytic leukemia by combining Idelalisib and GS-9973, a novel spleen tyrosine kinase (Syk) inhibitor.

Burke RT, Meadows S, Loriaux MM, Currie KS, Mitchell SA, Maciejewski P, Clarke AS, Dipaolo JA, Druker BJ, Lannutti BJ, Spurgeon SE.

Oncotarget. 2014 Feb 28;5(4):908-15.

3.

A triplex ribozyme expression system based on a single hairpin ribozyme.

Aquino-Jarquin G, Benítez-Hess ML, DiPaolo JA, Alvarez-Salas LM.

Oligonucleotides. 2008 Sep;18(3):213-24. doi: 10.1089/oli.2008.0130.

4.

Molecular approaches to cervical cancer therapy.

Alvarez-Salas LM, DiPaolo JA.

Curr Drug Discov Technol. 2007 Oct;4(3):208-19. Review.

PMID:
17986003
5.

Effect of combined antisense oligodeoxynucleotides directed against the human papillomavirus type 16 on cervical carcinoma cells.

Márquez-Gutiérrez MA, Benítez-Hess ML, DiPaolo JA, Alvarez-Salas LM.

Arch Med Res. 2007 Oct;38(7):730-8. Epub 2007 Jul 26.

PMID:
17845891
6.

YY-1 and c-Jun transcription factors participate in the repression of the human involucrin promoter.

Alvarez-Salas LM, Benitez-Hess ML, Dipaolo JA.

Int J Oncol. 2005 Jan;26(1):259-66.

PMID:
15586248
7.

Advances in the development of therapeutic nucleic acids against cervical cancer.

DiPaolo JA, Alvarez-Salas LM.

Expert Opin Biol Ther. 2004 Aug;4(8):1251-64. Review.

PMID:
15268660
8.

Antisense activity detection by inhibition of fluorescence resonance energy transfer.

Benítez-Hess ML, DiPaolo JA, Alvarez-Salas LM.

Luminescence. 2004 Mar-Apr;19(2):85-93.

PMID:
15098208
9.

Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.

Alvarez-Salas LM, Benítez-Hess ML, DiPaolo JA.

Antivir Ther. 2003 Aug;8(4):265-78. Review.

PMID:
14518695
10.

Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix.

Tran-Thanh D, Provencher D, Koushik A, Duarte-Franco E, Kessous A, Drouin P, Wheeler CM, Dubuc-Lissoir J, Gauthier P, Allaire G, Vauclair R, Dipaolo JA, Gravitt P, Franco E, Coutlée F.

Am J Obstet Gynecol. 2003 Jan;188(1):129-34.

PMID:
12548206
11.

Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old woman.

Einstein MH, Cruz Y, El-Awady MK, Popescu NC, DiPaolo JA, van Ranst M, Kadish AS, Romney S, Runowicz CD, Burk RD.

Clin Cancer Res. 2002 Feb;8(2):549-54.

12.

Growth inhibition of cervical tumor cells by antisense oligodeoxynucleotides directed to the human papillomavirus type 16 E6 gene.

Alvarez-Salas LM, Arpawong TE, DiPaolo JA.

Antisense Nucleic Acid Drug Dev. 1999 Oct;9(5):441-50.

PMID:
10555151
13.

Molecular aspects of neoplasia of Syrian hamster cells transformed in vitro by chemical carcinogens.

Notario V, DiPaolo JA.

Toxicol Lett. 1998 Aug;96-97:221-30. Review.

PMID:
9820671
14.
15.

Sites of recombinant adeno-associated virus integration.

Rivadeneira ED, Popescu NC, Zimonjic DB, Cheng GS, Nelson PJ, Ross MD, DiPaolo JA, Klotman ME.

Int J Oncol. 1998 Apr;12(4):805-10.

PMID:
9499439
16.

Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes.

Alvarez-Salas LM, Cullinan AE, Siwkowski A, Hampel A, DiPaolo JA.

Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1189-94.

17.

Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions.

Kim CY, Tsai MH, Osmanian C, Graeber TG, Lee JE, Giffard RG, DiPaolo JA, Peehl DM, Giaccia AJ.

Cancer Res. 1997 Oct 1;57(19):4200-4.

19.

Papillomaviruses and potential copathogens.

DiPaolo JA, Popescu NC, Woodworth CD, Zimonjic DB.

Toxicol Lett. 1996 Nov;88(1-3):1-7. Review.

PMID:
8920709
20.

Enhancement of TAT-induced transactivation of the HIV-1 LTR by two genomic fragments of HHV-6.

Garzino-Demo A, Chen M, Lusso P, Berneman Z, DiPaolo JA.

J Med Virol. 1996 Sep;50(1):20-4.

PMID:
8890036
21.

Tissue-specific expression, evolutionary conservation and localization of the cph proto-oncogene on Syrian hamster chromosome X.

Velasco JA, Zimonjic DB, Popescu NC, Cansado J, DiPaolo JA, Albor A, Notario V.

Oncogene. 1996 Jun 20;12(12):2713-7.

PMID:
8700531
22.

Immortalization of human adult prostatic adenocarcinoma cells by human papilloma virus HPV16 and -18 DNA.

Naghashfar Z, DiPaolo JA, Woodworth CD, Passaniti A.

Cancer Lett. 1996 Feb 27;100(1-2):47-54.

PMID:
8620453
23.

CDKN2 in HPV-positive and HPV-negative cervical-carcinoma cell lines.

Kelley MJ, Otterson GA, Kaye FJ, Popescu NC, Johnson BE, Dipaolo JA.

Int J Cancer. 1995 Oct 9;63(2):226-30.

PMID:
7591209
24.

Human herpesvirus 6 as a potential copathogen.

Ablashi DV, Bernbaum J, DiPaolo JA.

Trends Microbiol. 1995 Aug;3(8):324-7. Review.

PMID:
8528618
25.

Molecular cytogenetics of human papillomavirus-negative cervical carcinoma cell lines.

Zimonjic DB, Simpson S, Popescu NC, DiPaolo JA.

Cancer Genet Cytogenet. 1995 Jul 1;82(1):1-8.

PMID:
7627928
26.

Transcriptional repression in normal human keratinocytes by wild-type and mutant p53.

Alvarez-Salas LM, Velazquez A, Lopez-Bayghen E, Woodworth CD, Garrido E, Gariglio P, DiPaolo JA.

Cancer Lett. 1995 May 4;91(1):85-92.

PMID:
7750099
27.
28.

Detection of human herpesvirus 6 and human papillomavirus 16 in cervical carcinoma.

Chen M, Wang H, Woodworth CD, Lusso P, Berneman Z, Kingma D, Delgado G, DiPaolo JA.

Am J Pathol. 1994 Dec;145(6):1509-16.

29.

cph, a novel oncogene which cooperates with H-ras in the transformation of NIH3T3 fibroblasts.

Velasco JA, Castro R, Avila MA, Laborda J, DiPaolo JA, Cansado J, Notario V.

Oncogene. 1994 Jul;9(7):2065-9.

PMID:
8208552
30.

Detection of human herpesvirus-6 in paraffin-embedded tissue of cervical cancer by polymerase chain reaction.

Wang H, Chen M, Berneman ZN, Delgado G, DiPaolo JA.

J Virol Methods. 1994 May;47(3):297-305.

PMID:
8071418
31.

Human herpesvirus 6 infects cervical epithelial cells and transactivates human papillomavirus gene expression.

Chen M, Popescu N, Woodworth C, Berneman Z, Corbellino M, Lusso P, Ablashi DV, DiPaolo JA.

J Virol. 1994 Feb;68(2):1173-8.

32.

Chromosomal organization of viral integration sites in human papillomavirus-immortalized human keratinocyte cell lines.

Zimonjic DB, Popescu ND, DiPaolo JA.

Cancer Genet Cytogenet. 1994 Jan;72(1):39-43.

PMID:
8111737
33.
34.

A Burkitt lymphoma cell line with integrated Epstein-Barr virus at a stable chromosome modification site.

Popescu NC, Chen MC, Simpson S, Solinas S, DiPaolo JA.

Virology. 1993 Jul;195(1):248-51.

PMID:
8391183
35.

Cytokine modulation of immune defenses in cervical cancer.

Evans CH, Flugelman AA, DiPaolo JA.

Oncology. 1993 Jul-Aug;50(4):245-51. Review.

PMID:
8388555
36.

Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.

DiPaolo JA, Popescu NC, Alvarez L, Woodworth CD.

Crit Rev Oncog. 1993;4(4):337-60. Review.

PMID:
8394744
37.

Molecular control of human papillomavirus RNA expression in neoplasia.

DiPaolo JA, Woodworth CD.

Basic Life Sci. 1993;61:239-46. No abstract available.

PMID:
8304934
38.
39.

Cytogenetics of cervical neoplasia.

Popescu NC, DiPaolo JA.

Cancer Genet Cytogenet. 1992 Jun;60(2):214-5. No abstract available.

PMID:
1318784
40.
41.
42.

Differences in retention and expression of transfected human cytomegalovirus Towne XbaI-E transforming fragment in human cervical and NIH 3T3 lines.

Choudhury S, Woodworth CD, Inamdar A, el-Beik T, DiPaolo JA, Rosenthal LJ.

Intervirology. 1992;33(4):187-96.

PMID:
1326497
43.

The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis.

Auborn KJ, Woodworth C, DiPaolo JA, Bradlow HL.

Int J Cancer. 1991 Dec 2;49(6):867-9.

PMID:
1660039
45.

Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens.

Notario V, Castro R, Flessate DM, Doniger J, DiPaolo JA.

Oncogene. 1990 Sep;5(9):1425-30.

PMID:
2216466
46.

Human cervical cells immortalized in vitro with oncogenic human papillomavirus DNA differentiate dysplastically in vivo.

Waggoner SE, Woodworth CD, Stoler MH, Barnes WA, Delgado G, DiPaolo JA.

Gynecol Oncol. 1990 Sep;38(3):407-12.

PMID:
2172120
47.

Polyomavirus-based shuttle vectors for studying mechanisms of mutagenesis in rodent cells.

Zernik-Kobak M, Pirsel M, Doniger J, DiPaolo JA, Levine AS, Dixon K.

Mutat Res. 1990 Sep;242(1):57-65.

PMID:
2168017
48.

HSV-2-induced tumorigenicity in HPV16-immortalized human genital keratinocytes.

DiPaolo JA, Woodworth CD, Popescu NC, Koval DL, Lopez JV, Doniger J.

Virology. 1990 Aug;177(2):777-9.

PMID:
2164733
49.

Human cervical and foreskin epithelial cells immortalized by human papillomavirus DNAs exhibit dysplastic differentiation in vivo.

Woodworth CD, Waggoner S, Barnes W, Stoler MH, DiPaolo JA.

Cancer Res. 1990 Jun 15;50(12):3709-15.

50.

Viral integration, fragile sites, and proto-oncogenes in human neoplasia.

Popescu NC, Zimonjic D, DiPaolo JA.

Hum Genet. 1990 Apr;84(5):383-6.

PMID:
2323772

Supplemental Content

Loading ...
Support Center